Baseline 18F-FDG PET radiomic features as predictors of 2-year event-free survival in diffuse large B cell lymphomas treated with immunochemotherapy
Top Cited Papers
- 4 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Radiology
- Vol. 30 (8), 4623-4632
- https://doi.org/10.1007/s00330-020-06815-8
Abstract
To explore the prognostic value of positron emission tomography (PET) radiomic features in the field of diffuse large B cell lymphoma (DLBCL) treated with a first-line immunochemotherapy.This publication has 41 references indexed in Scilit:
- Signature of survival: a 18F-FDG PET based whole-liver radiomic analysis predicts survival after 90Y-TARE for hepatocellular carcinomaOncotarget, 2017
- Textural features and SUV-based variables assessed by dual time point 18F-FDG PET/CT in locally advanced breast cancerAnnals of Nuclear Medicine, 2017
- EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studiesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2017
- Baseline Metabolic Tumor Volume Predicts Outcome in High–Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter StudiesJournal of Clinical Oncology, 2016
- FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2016
- Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2015
- Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working GroupJournal of Clinical Oncology, 2014
- F‐18 FDG PET/CT quantization parameters as predictors of outcome in patients with diffuse large B‐cell lymphomaEuropean Journal of Haematology, 2014
- High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphomaInternational Journal of Hematology, 2011
- 18F-FDG Avidity in Lymphoma Readdressed: A Study of 766 PatientsJournal of Nuclear Medicine, 2009